Fast-Food Chains Adapt Menus for GLP-1 Weight-Loss Drug Users
Fast-food chains are increasingly modifying their menus to include more protein-rich and low-calorie options aimed at customers using GLP-1 weight-loss drugs. Recently, McDonald's announced plans to introduce healthier menu items, such as grilled chicken sandwiches, wraps, and egg bites. This initiative is part of a broader strategy where McDonald's intends to invest $8.5 billion over the next decade to refresh its global restaurant offerings.
According to McDonald's CEO Chris Kempczinski, the company recognizes that even those on GLP-1 medications still crave fast food. "We're going to evolve our menu to make sure it reflects where we think that consumer is going to be looking for in the future," he stated in an interview with CNBC. Skye Anderson, president of McDonald's USA, emphasized that the company is adapting its offerings as millions of GLP-1 users and other Americans seek to increase their protein intake.
Anderson noted, "We don't need to win a new base of customers into McDonald's. Instead, we need to keep giving them more reasons to make McDonald's their first choice as their eating habits evolve." She highlighted the demand for more protein, greater portion flexibility, and food that satisfies without overwhelming consumers.
Other fast-food chains are also making similar adjustments to their menus to support customers in achieving their weight management goals. For instance, Shake Shack recently launched its "Good Fit Menu," which features gluten-free, vegetarian, and GLP-1-friendly options. Most of the burgers on this menu are served in lettuce wraps instead of traditional buns, catering to those seeking lower-calorie alternatives.
Chipotle's New Offerings for GLP-1 Users
Chipotle has also joined the trend by creating a page on its website dedicated to options that assist individuals on their "GLP-1 journey." Their offerings include a low-calorie chicken bowl with lettuce and a high-fiber chicken bowl served with rice.
Shifts in Consumer Spending Reflect Menu Adaptations
Research published in the Journal of Marketing Research indicates that households with at least one GLP-1 user reduced their spending at fast-food chains, coffee shops, and other restaurants by 8% within the first six months of starting the medication. This shift in consumer behavior underscores the importance of fast-food chains adapting their menus to remain relevant to this audience.
David Portalatin, senior vice president at market research firm Circana, remarked, "It is important to have things on the menu that are relevant to that audience. I think what you're going to see is more diversity across the menu."